Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adjunctive Triamcinolone for Ahmed Glaucoma Valve Implantation
NCT02653963Completed
- Sponsor
- Shahid Beheshti University of Medical Sciences
- Start
- Sep 2014
- Primary completion
- Apr 2016
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Randomised, triple-blind trial of triamcinolone acetonide in refractory glaucoma (2 arms), sponsored by Shahid Beheshti University of Medical Sciences. Primary endpoint: Cumulative probability of success at 1 year. Started Sep 2014; status: completed.
02
Drugs
triamcinolone acetonide
03
Conditions
refractory glaucoma
Beyond the preview
Go deeper on NCT02653963.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02653963.